Předmět: |
|
Zdroj: |
Pediatrics Week; 7/14/2023, p402-402, 1p |
Abstrakt: |
Of them, nine patients were treatment naive at the time of initiation of CDED plus PEN (group A) and the remaining patients relapsed on biologics before treatment. Keywords: Barcelona; Spain; Europe; Bioengineering; Biological Therapy; Biologics; Biotechnology; Crohn's Disease; Digestive System Diseases and Conditions; Gastroenteritis; Gastroenterology; Gastrointestinal; Gastrointestinal Diseases and Conditions; Genetic Engineering; Genetically-Engineered Proteins; Health and Medicine; Pediatrics EN Barcelona Spain Europe Bioengineering Biological Therapy Biologics Biotechnology Crohn's Disease Digestive System Diseases and Conditions Gastroenteritis Gastroenterology Gastrointestinal Gastrointestinal Diseases and Conditions Genetic Engineering Genetically-Engineered Proteins Health and Medicine Pediatrics 402 402 1 07/10/23 20230714 NES 230714 2023 JUL 15 (NewsRx) -- By a News Reporter-Staff News Editor at Pediatrics Week -- New research on Biotechnology - Biologics is the subject of a report. [Extracted from the article] |
Databáze: |
Complementary Index |
Externí odkaz: |
|